PMGC HOLDINGS INC. Increase (Decrease) in Due to Related Parties
PMGC HOLDINGS INC. (ELAB) reported Increase (Decrease) in Due to Related Parties of -$10.79 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2026-08-14
- PMGC HOLDINGS INC. increase (decrease) in due to related parties for the quarter ending 2026-06-30 was -$7.86K.
- PMGC HOLDINGS INC. increase (decrease) in due to related parties for the quarter ending 2026-03-31 was -$2.93K.
- PMGC HOLDINGS INC. increase (decrease) in due to related parties for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- PMGC HOLDINGS INC. increase (decrease) in due to related parties for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PMGC HOLDINGS INC. increase (decrease) in due to related parties for fiscal 2025 was -$397.73K, a 200.00% decline from fiscal 2024.
- PMGC HOLDINGS INC. increase (decrease) in due to related parties for fiscal 2024 was $397.73K.
- PMGC HOLDINGS INC. increase (decrease) in due to related parties for fiscal 2023 was -$120.52K, a 200.43% decline from fiscal 2022.
- PMGC HOLDINGS INC. increase (decrease) in due to related parties for fiscal 2022 was $120.00K.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 6 month | Increase (Decrease) in Due to Related Parties 9 month | Increase (Decrease) in Due to Related Parties 9 month as first filed | Increase (Decrease) in Due to Related Parties 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$7.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$10.79K 10-Q · filed 2026-08-14 | -$10.79K derived: sum of 3 quarters · filed 2026-08-14 | -$10.79K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$2.93K 10-Q · filed 2026-05-15 | -$2.93K derived: sum of 2 quarters · filed 2026-05-15 | -$2.93K derived: sum of 3 quarters · filed 2026-05-15 | -$2.93K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | -$397.73K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | -$397.73K 10-Q · filed 2025-11-14 | -$206.83K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$397.73K 10-Q · filed 2026-08-14 | -$206.83K derived: sum of 3 quarters · filed 2026-08-14 | -$50.31K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$397.73K 10-Q · filed 2026-05-15 | -$206.83K derived: sum of 2 quarters · filed 2026-05-15 | -$50.31K derived: sum of 3 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $190.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $347.42K derived: sum of 2 quarters · filed 2026-03-30 | $397.73K 10-K · filed 2026-03-30 | ||
| 2024-09-30 | $156.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $206.83K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $50.31K 10-Q · filed 2025-08-13 | ||||
| 2023-12-31 | -$200.52K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$180.52K derived: sum of 2 quarters · filed 2025-03-28 | -$150.52K derived: sum of 3 quarters · filed 2025-03-28 | -$120.52K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $50.00K derived: sum of 2 quarters · filed 2024-11-14 | $80.00K 10-Q · filed 2024-11-14 | $80.00M 10-Q · filed 2023-12-11 | -$89.80M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $60.00K 10-Q · filed 2024-08-14 | -$89.82M derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $30.00K 10-Q · filed 2024-05-15 | -$89.85M derived: sum of 2 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$89.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $120.00K 10-K · filed 2024-03-29 | |||
| 2022-09-30 | $90.00M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |